ロード中...
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
BACKGROUND: High orphan drug prices have gained the attention of payers and policy makers. These prices may reflect the need to recoup the cost of drug development from a small patient pool. However, estimates of the cost of orphan drug development are sparse. METHODS: Using publicly available data,...
保存先:
| 出版年: | Orphanet J Rare Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327525/ https://ncbi.nlm.nih.gov/pubmed/30630499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-018-0990-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|